PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Louisiana State University Cancer Center, New Orleans, LA, United States.\', \'Department of Surgery, Ochsner Medical Center, New Orleans, LA, United States.\', \'Department of Genetics, LSU Health, New Orleans, LA, United States.\', \'Department of Pediatrics, LSU Health, New Orleans, LA, United States.\', \'Department of Pathology LSU Health, New Orleans, LA, United States.\', \'Tissue Biorepository, Ochsner Medical Center, New Orleans, LA, United States.\', \'Department of Biochemistry, LSU Health, New Orleans, LA, United States.\', \'Department of Internal Medicine, Ochsner Medical Center, New Orleans, LA, United States.\', \'School of Public Health, LSU Health, New Orleans, LA, United States.\', \'Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.\', \'Division of Emergency Medicine, Boston Children\'s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, United States.\', \'Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, Children\'s Healthcare of Atlanta, Atlanta, GA, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.695972
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34341659
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all